Thomas Gilley - 10 Nov 2022 Form 4 Insider Report for BIO KEY INTERNATIONAL INC (BKYI)

Reporting relationship: Director
Issuer ticker: BKYI
Reported as of: 10 Nov 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Nov 2022, 14:23:40 UTC
Prior SEC filing: 12 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Thomas Gilley

Key filing fact

Thomas Gilley filed Form 4 for BIO KEY INTERNATIONAL INC (BKYI) on 14 Nov 2022.

Key facts

This page summarizes Thomas Gilley's Form 4 filing for BIO KEY INTERNATIONAL INC (BKYI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Nov 2022, 14:23.

Change

Previous filing in this sequence was filed on 12 Aug 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BKYI transaction

Common Stock

Award

Transaction value: $0
Shares: +2,098
Change %: +15%
Price: $0.000000
Shares after: 16,290
Date: 10 Nov 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares issued to the Reporting Person on November 10, 2022, under the Issuer's Amended and Restated 2015 Equity Incentive Plan in payment of board meeting attendance fees.